4//SEC Filing
Niklason Laura E 4
Accession 0001818382-25-000113
CIK 0001818382other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:31 PM ET
Size
8.8 KB
Accession
0001818382-25-000113
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Niklason Laura E
DirectorPresident, CEO and Director
Transactions
- Award
Stock Options (right to buy)
2025-06-12+0→ 0 total(indirect: By Spouse)Exercise: $2.41Exp: 2035-06-12→ Common Stock (80,000 underlying)
Holdings
- 243,851
Common Stock
- 2,241,045(indirect: By LLC)
Common Stock
- 1,148,240(indirect: By Trust)
Common Stock
- 0(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]This Form 4 amends the previously reported number of shares owned by Brady W. Dougan and Ayabudge LLC, an entity controlled by Brady W. Dougan, to correct an error in a Form 4 filed by the Reporting Person on August 21, 2023 (the "Original Form 4"). The Original Form 4 reported the sale of 510,161 shares of common stock of Humacyte, Inc. as a sale by Ayabudge LLC; however, these shares were sold by Mr. Dougan.
- [F2]The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001878075
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:31 PM ET
- Size
- 8.8 KB